US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,477.45

+6.670.45%

Number of Gainers:10

Number of Losers:8

Number of Flat:1

PE:- -

High:1,484.26

Open:1,470.85

Low:1,469.38

Close:1,470.74

Volume:102.98M

Turnover:3.24B

Market Cap:1.21T

Float Cap:1.19T

Loading ...

Ocugen Inc. and Kwangdong Pharmaceutical Finalize $7.5 Million License Agreement for OCU400 Gene Therapy in Korea

Ocugen Inc - to GET Royalties Equaling 25% of Net Sales of Ocu400 Generated by Kwangdong

THOMSON REUTERS

Ocugen Inc - Upfront Fees and Milestone Payments Totaling up to $7.5 Mln

THOMSON REUTERS

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of Ocu400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

THOMSON REUTERS

Ocugen Inc - Under Deal, Potential Sales Milestones of $180 Mln in First 10 Years

THOMSON REUTERS

U.S. Stocks to Watch: Nvidia, Warner Bros., Gemini Space Station, Tesla, Corteva, and More

Update: Market Chatter: AstraZeneca Pauses $271 Million Cambridge Project

MT Newswires Live

AstraZeneca Pauses Plans for $271 Million Expansion of U.K. Site

Press Release: Hexagon announces organisational updates and further details around the potential spin-off of Octave

Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc

Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?

3 No-Brainer Dividend Stocks to Buy in September

Where the Uber-Rich Are Investing Now -- Barron's

Moderna says research has demonstrated safety profile of Spikevax

Moderna, Pfizer Stocks Fall as Trump Officials Reportedly Link COVID Shots to Child Deaths

Why BioNTech Stock Sank by More Than 7% Today

Gilead beats whistleblower lawsuit over hepatitis C drugs

Aethlon Medical Announces New Share Structure Update

AstraZeneca pauses planned $270M investment in Britain, Reuters reports

US Hhs Says Until Vaccine Safety Data Is Publicly Shared, All Reports on It Should Be Considered Pure Speculation

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1477.4088,"timestamp":1758138956930,"preClose":1470.7393,"halted":0,"volume":102981478,"delay":0,"changeRate":0.004535,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":6.669556,"latestTime":"09-17 15:55:57 EDT","open":1470.8473,"high":1484.2612,"low":1469.3794,"amount":3240338576.538107,"amplitude":0.010119,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.836858,"peRate":20.735352,"turnoverRate":0.006705,"increases":10,"decrements":8,"flats":1,"marketCap":1212018975408,"floatMarketCap":1192828297683},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1484.2612,"amplitude":0.010119,"preClose":1470.7393,"low":1469.3794,"pbRate":"3.836858","latestPrice":1477.451,"volume":102977779,"delay":0,"open":1470.8473,"prevYearClose":1274.8187,"prevWeekClose":1488.5051,"prevMonthClose":1489.44,"prevQuarterClose":1377.5769,"fiveDayClose":1484.1697,"twentyDayClose":1501.6229,"sixtyDayClose":1360.6882,"secType":"PLATE","market":"US","turnoverRate":0.006705,"peRate":20.735352,"marketCap":1212018975408,"floatMarketCap":1192828297683,"timestamp":1758138956462,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":8,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567118591","title":"Ocugen Inc. and Kwangdong Pharmaceutical Finalize $7.5 Million License Agreement for OCU400 Gene Therapy in Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118591","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118591?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:03","pubTimestamp":1757930595,"startTime":"0","endTime":"0","summary":"Ocugen, Inc., a leader in gene therapies for blindness diseases, has announced a licensing agreement with Kwangdong Pharmaceutical Co., Ltd. for the exclusive rights to OCU400, a novel modifier gene therapy for retinitis pigmentosa, in Korea. The agreement includes upfront fees and near-term development milestone payments totaling up to $7.5 million, with potential sales milestones of $180 million or more in the first ten years of commercialization. Ocugen will also receive a 25% royalty on net sales, while manufacturing and supplying OCU400 under a supply agreement. With an estimated 7,000 individuals affected by retinitis pigmentosa in Korea, this partnership is set to make a significant impact in the field of ophthalmic gene therapy. Ocugen is advancing OCU400 through Phase 3 clinical development, with a U.S. Biologics License Application filing targeted for 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT stri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL9HzH4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN","BK4588","NDAQ","BK4563","BK4139","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","LU0314104364.USD","IE00BGHQF748.EUR","LU2210150020.SGD","LU2095319765.USD","BK4112","BK4568","IE00BKPKM429.USD","BK4585"],"gpt_icon":0},{"id":"2567511854","title":"Ocugen Inc - to GET Royalties Equaling 25% of Net Sales of Ocu400 Generated by Kwangdong","url":"https://stock-news.laohu8.com/highlight/detail?id=2567511854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567511854?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:03","pubTimestamp":1757930580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUA9VJLJ7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCGN","BK4563","BK4139","BK4568"],"gpt_icon":0},{"id":"2567185141","title":"Ocugen Inc - Upfront Fees and Milestone Payments Totaling up to $7.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2567185141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567185141?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:03","pubTimestamp":1757930580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUA9VJLJ7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","BK4563","OCGN"],"gpt_icon":0},{"id":"2567118519","title":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of Ocu400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118519","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118519?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:03","pubTimestamp":1757930580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUA9VJLJ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCGN","BK4563","BK4139","BK4568"],"gpt_icon":0},{"id":"2567118511","title":"Ocugen Inc - Under Deal, Potential Sales Milestones of $180 Mln in First 10 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118511?lang=en_us&edition=fundamental","pubTime":"2025-09-15 18:03","pubTimestamp":1757930580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUA9VJLJ7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4568","BK4139","OCGN"],"gpt_icon":0},{"id":"2567119086","title":"U.S. Stocks to Watch: Nvidia, Warner Bros., Gemini Space Station, Tesla, Corteva, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119086","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119086?lang=en_us&edition=fundamental","pubTime":"2025-09-15 17:36","pubTimestamp":1757928977,"startTime":"0","endTime":"0","summary":"Stock futures edged higher Monday as investors were cautious to make any big moves ahead of this week's Federal Reserve interest-rate decision.These stocks were poised to make moves...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","LU1721428933.USD","LU1989763690.USD","IE00BFSS7M15.SGD","LU0124676726.USD","LU2473716301.USD","LU0868494617.USD","LU1035775433.USD","LU2237957811.SGD","IE00BJLML261.HKD","LU2237957902.USD","LU0321505439.SGD","LU0957808578.USD","IE00B19Z9505.USD","LU1935042991.SGD","LU0058720904.USD","BK4532","LU1839511570.USD","IE000M9KFDE8.USD","LU2463028550.USD","LU1791710582.SGD","LU1629891620.HKD","US6M.BOND","LU0342679015.USD","LU0672654240.SGD","LU0466842654.USD","SG9999001424.SGD","LU2756315318.SGD","LU0724617625.USD","DRI","LU1923622291.USD","LU0208291251.USD","LU2361044949.HKD","LU0225771236.USD","HK0000320264.USD","LU1435385759.SGD","LU2381873111.SGD","BK4534","IE0034235188.USD","BK4592","LU1066051498.USD","LU1803068979.SGD","LU0251142724.SGD","LU0942090050.USD","LU2125909593.SGD","SG9999000418.SGD","IE00B1BXHZ80.USD","US12M.BOND","IE00BLSP4452.SGD","BK4099","LU1064131342.USD","LU2211815571.USD","IE00B7SZLL34.SGD","BK4503","LU0786609619.USD","IE0004445239.USD","LU1244550494.USD","IE00BK4W5L77.USD","LU0823411888.USD","BK4566","LU0444971666.USD","LU0545039389.USD","2NVD.UK","NVDU","LU0476273544.USD","LU2462157665.USD","LU0979878070.USD","LU1935043536.SGD","LU0210536198.USD","LU2023250504.SGD","LU2065171402.SGD","LU2746668461.USD","LU2360107168.USD","LU0878866978.SGD","IE00BDRTCR15.USD","LU2168564222.USD","SG9999014575.USD","LU0128525689.USD","LU0080751232.USD","LU0127658192.USD","LU0345770993.USD","LU2054465674.USD","IE00BZ1G4Q59.USD","MRNA","LU0742534661.SGD","BK4223","LU0390134368.USD","LU2168564065.EUR","IE00BN29S564.USD","NVDX","HK0000306685.HKD","LU0198837287.USD","LU1951200564.SGD","LU2087621335.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU2471134796.USD","BK4097","LU0234570918.USD","LU2543165471.USD","LU0079474960.USD","LU1066053197.SGD","LU2552382132.HKD","BK4574","LU0157215616.USD","LU1720051017.SGD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU2294711713.HKD","SG9999014559.SGD","LU0820561909.HKD","TSLA","LU0354030438.USD","LU1935042215.USD","LU0823434583.USD","SGXZ81514606.USD","LU0823421333.USD","HK0000320223.HKD","LU0321505868.SGD","LU2236285917.USD","LU0107464264.USD","LU1861127337.USD","IE0009356076.USD","LU2430703178.SGD","TSLL","LU0070302665.USD","IE00BJJMRY28.SGD","LU0306806265.USD","NVD2.UK","LU2191332357.HKD","SG9999015952.SGD","SG9999004303.SGD","LU2023250330.USD","LU0069063385.USD","SG9999015986.USD","LU0310800379.SGD","LU0444973449.USD","LU2592432038.USD","LU1267930730.SGD","LU2210150020.SGD","LU2360106780.USD","US5Y.BOND","LU1506573853.SGD","LU1989773731.SGD","LU0345768153.USD","LU0048584097.USD","LU1868836914.USD","LU2092627202.USD","LU0094547139.USD","LU0964807845.USD","LU0820562030.AUD","LU1116320737.USD","LU1868837300.USD","IE00B775SV38.USD","LU0154245756.USD","LU1791710400.SGD","IE00B7KXQ091.USD","LU0316494557.USD","BK4194","LU0057025933.USD","LU1366333091.USD","LU2506951792.HKD","LU1974910355.USD","BK4559","LU1023059063.AUD","LU2896262040.SGD","LU2023251221.USD","GEMI","BK4108","LU2413666426.HKD","LU0882574139.USD","LU1712237335.SGD","SG9999014542.SGD","SNVD.UK","LU1084165304.USD","US30Y.BOND","LU0289961442.SGD","BK4007","LU1861220033.SGD","SG9999015978.USD","LU0077335932.USD","BK4579","LU0708994859.HKD","LU2065171311.SGD","LU2097344357.USD","BK4212","LU0109392836.USD","IE00BSNM7G36.USD","LU0347712357.USD","LU1280957306.USD","NVDS.UK","LU0511384066.AUD","LU0122379950.USD","LU1066051225.USD","LU0056508442.USD","NVDD","PFE.AU","LU0210528500.USD","LU1935042488.USD","LU0823414478.USD","SG9999003800.SGD","LU2420271590.USD","LU2106854487.HKD","LU1267930573.SGD","CBRL","LU0187121727.USD","LU0433182093.SGD","IE00BK4W5M84.HKD","BK4587","LU0266013472.USD","GB00BDT5M118.USD","LU0965509283.SGD","BK4588","LU0553294199.USD","LU2458330169.SGD","IE0004445015.USD","LU2125909759.SGD","LU0070217475.USD","LU1989764748.USD","LU2430703251.USD","BK4088","BK4550","BK4581","LU1815333072.USD","IE00BFSS8Q28.SGD","LU1551013342.USD","LU1232071149.USD","LU2242650005.HKD","LU2491049909.HKD","SG9999015358.SGD","LU0048573561.USD","LU1699723380.USD","LU2272731865.HKD","LU0274383776.USD","LU0068578508.USD","IE00BZ199S13.USD","LU0289739343.SGD","LU0861579265.USD","LU1244550221.USD","LU2602419157.SGD","LU1720051108.HKD","BK4511","LU2237438978.USD","BK4568","ORCL","LU1989772923.USD","LU0823421416.USD","LU2089985449.USD","LU0353189680.USD","LU0211328371.USD","LU0787776722.HKD","LU1815336760.USD","LU0267386448.USD","LU2750360997.AUD","LU1642822529.SGD","BK4112","LU2452424414.USD","LU2458330243.SGD","LU2083900584.USD","LU1883839398.USD","LU2756315664.SGD","SG9999014567.USD","LU2213496289.HKD","IE0034235295.USD","BK4585","IE00B3M56506.USD","LU1430594728.SGD","IE00B4JS1V06.HKD","LU2326559502.SGD","LU1868836591.USD","LU0072462426.USD","LU2322448957.HKD","LU1923622614.USD","BK4554","LU1069347547.HKD","3NVD.UK","LU0472753341.HKD","LU0354030511.USD","LU1316542783.SGD","BK4504","BK4555","LU1127390331.HKD","LU1992135399.USD","LU1244550577.SGD","IE00BHPRN162.USD","LU0265550946.USD","LU2471134523.USD","LU2413666699.HKD","LU0417517546.SGD","LU1242518857.USD","BK4552","LU1691799644.USD","LU1861215975.USD","TSYW.SI","LU2272731782.SGD","LU0256863811.USD","BK4605","LU2471134952.CNY","IE00BQXX3F31.USD","IE00BJTD4N35.SGD","LU1852331112.SGD","LU1989772840.SGD","FDS","LU0097036916.USD","LU0661504455.SGD","LU2089284900.SGD","LU0823434740.USD","LU0175139822.USD","IE00BJTD4V19.USD","LU1496350502.SGD","LU1914381329.SGD","LU1674673428.USD","LU1323610961.USD","LU0053666078.USD","NVIW.SI","LU2168564149.EUR","SG9999002224.SGD","LU0211327993.USD","LU0949170772.SGD","BK4604","LU0029864427.USD","LU1934455277.USD","LU1201861249.SGD","LU2357125470.USD","LU0557290698.USD","BK4529","LU1989764664.SGD","LU1894683348.USD","IE00B3S45H60.SGD","IE00BN8TJ469.HKD","LU1989763427.SGD","LU2931357623.SGD","LU1935043023.USD","LU1917777945.USD","LU2028103732.USD","LU1242518931.SGD","LU0868494708.USD","LU0345769128.USD","LU0985320562.USD","LU1894683264.USD","SGXZ99366536.SGD","LU1821325948.USD","LU0494093205.USD","LU0306807586.USD","LU2403377893.USD","LU1116320901.HKD","LU0648001328.SGD","LU0256863902.USD","LU0251132253.USD","LU2552382058.USD","LU0823414551.USD","LU2168564495.EUR","LU1868837136.USD","LU1989763005.USD","LU2210149790.SGD","IE00BKPKM429.USD","BK4549","LU0320765489.SGD","LU2491050154.USD","LU1267930490.SGD","BK4567","US3Y.BOND","SG9999011175.SGD","IE00BD6J9T35.USD","LU2095319765.USD","LU1551013425.SGD","LU2456880835.USD","LU2065169927.USD","LU1496350171.SGD","LU1037948897.HKD","LU0289960550.SGD","LU0738911758.USD","BK4614","LU0096364046.USD","IE00BMPRXN33.USD","LU0158827781.USD","IE0004086264.USD","LU1923623000.USD","LU0154245673.USD","US7Y.BOND","LU0456855351.SGD","BK4538","LU2491050071.SGD","BK4533","LU0238689110.USD","LU1934455194.USD","LU0308772762.SGD","NVDY","LU0314106906.USD","BK7095","SG9999001176.USD","LU2272731600.USD","LU0082616367.USD","LU2242649171.HKD","SG9999013999.USD","LU2247934214.USD","LU0203202063.USD","LU0276348264.USD","WBD","LU1267930227.SGD","TYL","US10Y.BOND","LU2322448791.USD","LU2097344431.USD","NVDS","LU2286300806.USD","LU1037948541.HKD","LU1861558580.USD","LU0203201768.USD","LU0310800965.SGD","LU0109391861.USD","GIS","LU1366192091.USD","BK4551","LU1066051811.HKD","LU2264538146.SGD","LU2168563687.JPY","LU2360032135.SGD","LU2265009873.SGD","SG9999002232.USD","LEN","IE00BYXW3230.USD","LU0642271901.SGD","LU0081259029.USD","LU2125154935.USD","LU2249611893.SGD","LU1674673691.USD","IE00BMPRXQ63.HKD","LU0106261372.USD","IE00B19Z3B42.SGD","LU0985489474.SGD","FDX","DISCA","IE0004091025.USD","LU0210533765.USD","LU2108987350.USD","LU2092937148.SGD","LU0170899867.USD","LU0985481810.HKD","BK4139","NVD3.UK","LU2461242641.AUD","LU0006306889.USD","IE00BWXC8680.SGD","LU0528227936.USD","BK4612","LU2552382215.SGD","LU2125909916.SGD","LU0061475181.USD","BK4131","IE0002270589.USD","LU0225283273.USD","LU0096362180.USD","BK4141","LU0889565833.HKD","LU0353189763.USD","LU1814569148.SGD","BK4516","PFE","LU0128525929.USD","IE00B5949003.HKD","CTVA","LU0345769631.USD","LU1934455863.HKD","IE00B19Z8X17.USD","NVD","LU0320765059.SGD","LU0689626769.HKD","LU2271345857.HKD","LU0965508806.USD","LU0820561818.USD","LU2357305700.SGD","LU0965509010.AUD","LU0251131958.USD","LU1861559042.SGD","LU0943347566.SGD","LU2433249047.HKD","SGXZ57979304.SGD","LU0215105999.USD","LU0265550359.USD","NVDA","BK4501","LU0965509101.SGD","LU0980610538.SGD","IE00BKDWB100.SGD","LU2244417387.USD","LU2860962120.EUR","LU0130102774.USD","BK4598","SG9999015945.SGD","SG9999001176.SGD","LU0719512351.SGD","LU0788109477.HKD","LU2505996509.AUD","LU0314104364.USD","BK4543","LU2290526834.HKD","LU0225284248.USD","LU2750360641.GBP","LU0052756011.USD","SGXZ23171101.USD","LU0061474960.USD","BK4527","LU1585245621.USD","LU0289739699.SGD","IE00BMPRXR70.SGD","LU2125909247.SGD","LU2087625088.SGD","LU1057294990.SGD","LU2361045086.USD","LU0640476718.USD","LU1035773651.USD","IE00B775H168.HKD","LU1145028129.USD","LU0689472784.USD","PGRE","LU2505996681.GBP","LU2417539215.USD","LU2065170008.USD","LU0323591593.USD","HK0000306701.USD","LU0234572021.USD","LU0345768740.USD","LU1868836757.USD","LU0708995401.HKD","IE00BQXX3D17.EUR","BK4596","LU1119994496.HKD","BLSH","BK4548","LU2111349929.HKD","US2Y.BOND","LU2125154778.USD","IE00B1XK9C88.USD","BK4608","LU2250418816.HKD","LU1261432733.SGD","LU1623119135.USD","LU2063271972.USD","LU2089283258.USD","IE00BDCRKT87.USD","LU2077746001.SGD","LU1718418525.SGD","LU2361044865.SGD","LU0348723411.USD","IE00BJJMRX11.SGD","BK4023","LU0345770308.USD","LU1992135472.HKD","LU2471134879.HKD","LU0154236417.USD","LU1571399168.USD","LU1548497426.USD","BK4599","LU0061474705.USD","NVDL","LU2746668974.SGD","IE00B19Z8W00.USD","LU2487616109.SGD","IE0005OL40V9.USD","BK4528","IE0034235303.USD","LU0158827948.USD","LU0683600562.USD","LU1633808545.USD","LU1804176565.USD","LU1983260115.SGD","LU1951198990.SGD","LU1988902786.USD","LU0957791311.USD","LU2430703095.HKD","IE00BBT3K403.USD","LU1489326972.SGD","SG9999015341.SGD","LU1003077747.HKD","LU1429558221.USD","SGXZ51526630.SGD","LU1069344957.HKD","IE00BQXX3C00.GBP","BK4125","BK4209"],"gpt_icon":1},{"id":"2567192005","title":"Update: Market Chatter: AstraZeneca Pauses $271 Million Cambridge Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2567192005","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567192005?lang=en_us&edition=fundamental","pubTime":"2025-09-15 17:08","pubTimestamp":1757927280,"startTime":"0","endTime":"0","summary":"(Updates with comments from AstraZeneca in the first paragraph and stock move in the fifth paragraph.)AstraZeneca (AZN) said, in a statement to MT Newswires, the company constantly reassesses its inve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU2361044949.HKD","LU0203347892.USD","LU0211331839.USD","LU0234572021.USD","LU1983299246.USD","LU0965509101.SGD","SG9999002232.USD","IE00BN8TJ469.HKD","LU0208291251.USD","LU1069347547.HKD","LU2106854487.HKD","BK4550","LU0203345920.USD","LU0320765489.SGD","LU1829250122.USD","LU0965509010.AUD","LU1162221912.USD","SG9999013999.USD","LU1066051225.USD","IE00BJT1NW94.SGD","LU1917777945.USD","LU0265550946.USD","LU2236285917.USD","IE000M9KFDE8.USD","BK4568","IE00BFTCPJ56.SGD","LU0965508806.USD","SG9999001440.SGD","LU0985320562.USD","LU1057294990.SGD","LU1929549753.HKD","LU1571399168.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","MRK","LU1066051498.USD","LU1430594728.SGD","BK4534","LU0098860793.USD","LU0238689110.USD","LU1116320901.HKD","LU1941712348.USD","LU2462157665.USD","LU0320765646.SGD","AZN","LU1941712264.USD","LU1035773651.USD","LU0106261372.USD","SG9999014542.SGD"],"gpt_icon":0},{"id":"2567199993","title":"AstraZeneca Pauses Plans for $271 Million Expansion of U.K. Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2567199993","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567199993?lang=en_us&edition=fundamental","pubTime":"2025-09-15 15:35","pubTimestamp":1757921700,"startTime":"0","endTime":"0","summary":"AstraZeneca paused plans to invest 200 million pounds  in a U.K. research facility, marking a setback for the country's pharmaceutical sector.This represents the latest move by a major drugmaker to freeze or shelve planned investments in the U.K. as the industry seeks a more favorable commercial environment, with pressure mounting from the U.S. Trump administration to cut the cost of drugs for Americans.\"We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused,\" an AstraZeneca spokesperson said Monday.The company, Britain's biggest by market capitalization, disclosed the Cambridge plans in March 2024 along with a project in Liverpool, England, which it scrapped in January. Between those two announcements, the pharmaceutical group canceled or suspended 650 million pounds in planned U.K. investments that it had previously said would improve the country's public health and pandemic preparedness.AstraZeneca's change of plans is the lat","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","BK4568","AZN","LU2456880835.USD","BK4007","LU2236285917.USD","LU1829250122.USD","BK4588","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2567195516","title":"Press Release: Hexagon announces organisational updates and further details around the potential spin-off of Octave","url":"https://stock-news.laohu8.com/highlight/detail?id=2567195516","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567195516?lang=en_us&edition=fundamental","pubTime":"2025-09-15 14:24","pubTimestamp":1757917440,"startTime":"0","endTime":"0","summary":"-- Ben Maslen and Tony Zana to be appointed to the Octave executive team as. Chief Financial Officer and Chief Legal Officer & Corporate Secretary,executive team, as Chief Strategy Officer and Chief Legal Officer,On separation, Tony Zana will become Chief Legal Officer and Corporate Secretary of Octave. Tony is currently General Counsel and Chief Compliance Officer of Hexagon. Tony joined Hexagon in 2010 during the acquisition of Intergraph, where he was Vice President, General Counsel and Corporate Secretary and later served as Hexagon's Deputy General Counsel. Tony will remain as Hexagon's General Counsel and Chief Compliance Officer until the potential separation is completed.Ben is succeeded by Andreas Wenzel, who joins from ABB where he was CFO for ABB E-mobility, and previously Head of Strategy and M&A of ABB. Andreas joined Hexagon during August 2025 and will assume the role of Chief Strategy Officer of Hexagon and be a member of Hexagon's","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4551","HXGBY","BK4588","BK4139","BK4600","BK4535","BNTX","CFO","BK4023","BK4568","SDR","STRK","BK4157","BK4595","BK4585","BK4516","BK4596"],"gpt_icon":1},{"id":"2567609321","title":"Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2567609321","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567609321?lang=en_us&edition=fundamental","pubTime":"2025-09-15 12:06","pubTimestamp":1757909160,"startTime":"0","endTime":"0","summary":"Australian scientists who discovered how to \"turn off\" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation.MELBOURNE, Australia, Sept. 15, 2025 /PRNewswire/ -- Australian biotechnology investment and commercialisation incubator, Oncology One Pty Ltd, is pleased to report that PF-07248144, Pfizer Inc's clinical drug candidate discovered from Oncology One's out-licensed KAT6 inhibitor program, has now commenced a Phase 3 clinical trial, a key milestone.Quick facts:PF-07248144 is a selective catalytic inhibitor of KAT6 , members of the histone lysine acetyltransferase family of enzymes that are involved in regulating gene expression. In certain cancers, KAT6A/B gene activity is dysregulated promoting cancer cell growth. PF-07248144 suppresses this abnormal gene activity and thereby supresses cancer growth. Previous clinical trials have shown promise","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/jointly-discovered-kat6i-molecule-originating-from-australian-research-has-initiated-phase-3-in-hr-her2--breast-cancer-with-pfizer-inc-302555980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","LU1894683264.USD","HR","LU0456855351.SGD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999002224.SGD","BK4550","LU0306807586.USD","XKO.AU","BK4007","LU0306806265.USD","IE00BBT3K403.USD","LU0170899867.USD","LU0868494617.USD","BK4568","LU1894683348.USD","BK4534","LU0225284248.USD","LU1066051498.USD","PFE","SG9999013999.USD","XJO.AU","LU0225771236.USD","BK4592","BK4203","IE0002270589.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1057294990.SGD","SG9999002232.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4225","BK4533","BK4581","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0321505868.SGD","LU1023059063.AUD","BK4588","BK4585","SG9999001176.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999001176.USD","SG9999011175.SGD"],"gpt_icon":1},{"id":"2567215763","title":"Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2567215763","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567215763?lang=en_us&edition=fundamental","pubTime":"2025-09-15 03:32","pubTimestamp":1757878320,"startTime":"0","endTime":"0","summary":"Several top blue-chip stocks sport big dividend yields, but weak cash flow and sector headwinds raise questions of value trap versus smart buy.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/14/Blue-Chip-And-Bull-With-Stock-Market-Gra.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/14/Blue-Chip-And-Bull-With-Stock-Market-Gra.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/25/09/47659020/blue-chip-stocks-with-fat-dividends-smart-buy-or-value-trap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/09/47659020/blue-chip-stocks-with-fat-dividends-smart-buy-or-value-trap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["IE00BBT3K403.USD","LU1894683264.USD","BK4534","BK4588","IE00B19Z3B42.SGD","LU0058720904.USD","LU0234572021.USD","SG9999011175.SGD","LU0985481810.HKD","LU0868494617.USD","LU1066051498.USD","SG9999001176.USD","LU0321505868.SGD","LU0306806265.USD","LU0289739699.SGD","BK4585","BK4007","LU1023059063.AUD","LU1894683348.USD","BK4533","SG9999013999.USD","SG9999001176.SGD","LU0225771236.USD","BK4599","LU0321505439.SGD","LU1883839398.USD","LU1066053197.SGD","PFE","LU0306807586.USD","BK4581","BK4592","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0170899867.USD","BK4568","SG9999003800.SGD","BK4550","LU0122379950.USD","IE00BLSP4239.USD","LU0225284248.USD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999002224.SGD","SG9999002232.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2567118420","title":"3 No-Brainer Dividend Stocks to Buy in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118420","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118420?lang=en_us&edition=fundamental","pubTime":"2025-09-13 18:42","pubTimestamp":1757760120,"startTime":"0","endTime":"0","summary":"The attraction of these dividend stocks isn't limited to their dividends.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833243%2Fcouple-looking-at-laptop.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833243%2Fcouple-looking-at-laptop.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/09/13/3-no-brainer-dividend-stocks-to-buy-in-september/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/09/13/3-no-brainer-dividend-stocks-to-buy-in-september/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4585","BK4533","IE00BMG7P587.USD","IE00BD4GTT62.SGD","BK4082","BK4504","LU2133065610.SGD","BK4592","LU0122379950.USD","BK4581","LU0266013472.USD","LU2089984988.USD","SG9999002224.SGD","SG9999004303.SGD","IE00BD4GTV84.USD","LU1057294990.SGD","PEG","LU2211815571.USD","SG9999002232.USD","ABT","BK4566","LU1721429741.USD","LU2112291526.USD","BK4568","LU1023059063.AUD","LU1989763690.USD","IE00BJT1NW94.SGD","LU2324357040.USD","LU0234572021.USD","IE0002141913.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1914381329.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BMG7P926.USD","LU2346227817.USD","LU1989763427.SGD","IE00BFTCPJ56.SGD","SGXZ23171101.USD","IE00BD4GTW91.USD","IE00BMG7P819.SGD","LU0114720955.EUR","IE00BMG7P694.USD","BK4588","IE0009355771.USD","LU2468319806.SGD","LU0882574055.USD","LU2237957902.USD","LU2237957811.SGD"],"gpt_icon":0},{"id":"2567831601","title":"Where the Uber-Rich Are Investing Now -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2567831601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567831601?lang=en_us&edition=fundamental","pubTime":"2025-09-13 09:31","pubTimestamp":1757727060,"startTime":"0","endTime":"0","summary":"Goldman's Sara Naison-Tarajano works with many of the richest families in the world. By Abby Schultz. Sara Naison-Tarajano wears numerous hats at Goldman Sachs, where she works with many of the richest families in the world. A Goldman partner, she is global head of private wealth management capital markets, and Goldman Sachs Apex, which brings investment deals to client families. She is also co-head of One Goldman Sachs Family Office Initiative, addressing the needs of large family offices across the firm's businesses. And, she runs the Goldman Sachs Partner Family Office for top executives of the firm.Naison-Tarajano, who says that all of her roles \"sort of connect,\" has been at Goldman for 26 years, since joining the firm's analyst program right out of college.Goldman has surveyed professionals running the family offices of the uber-rich, two-thirds of which have assets of $1 billion or more, biennially since 2021, to glean insights into what drives their investment priorities and ou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","LU1814569148.SGD","LU2237443978.SGD","LU1791807156.HKD","LU1894683264.USD","LU2360107325.USD","LU1861214812.USD","LU2471134523.USD","LU0082616367.USD","LU1861219969.SGD","LU2237443549.SGD","LU2471134879.HKD","IE00BZ199S13.USD","BK4230","LU2237438978.USD","SG9999015978.USD","LU2750360997.AUD","BK4022","BK4568","BK4116","SG9999015986.USD","BK4548","BK4534","LU2237443895.HKD","LU1868836757.USD","LU0719512351.SGD","SG9999015945.SGD","LU0642271901.SGD","SGXZ31699556.SGD","LU1988902786.USD","LU2237443382.USD","IE0002270589.USD","BK4532","IE00BSNM7G36.USD","LU1804176565.USD","SGXZ51526630.SGD","MRNA","SG9999014898.SGD","SG9999018865.SGD","LU0061475181.USD","IE00BFMHRM44.USD","LU1064131342.USD","LU2087625088.SGD","LU0353189680.USD","BK4504","UBER","BK4536","BK4535","SG9999014914.USD"],"gpt_icon":1},{"id":"2567118803","title":"Moderna says research has demonstrated safety profile of Spikevax","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118803","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118803?lang=en_us&edition=fundamental","pubTime":"2025-09-13 08:45","pubTimestamp":1757724310,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) issued the following statement on the safety of Spikevax: “The safety of Spikevax is rigorously monitored by Moderna, the U.S. FDA, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-says-research-has-demonstrated-safety-profile-of-spikevax-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-says-research-has-demonstrated-safety-profile-of-spikevax-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4532","MRNA","BK4501","BK4139","BK4534","BK4588","BK4568","BK4548","BK4533","BK4585"],"gpt_icon":0},{"id":"2567390171","title":"Moderna, Pfizer Stocks Fall as Trump Officials Reportedly Link COVID Shots to Child Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2567390171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567390171?lang=en_us&edition=fundamental","pubTime":"2025-09-13 08:09","pubTimestamp":1757722168,"startTime":"0","endTime":"0","summary":"Stocks of COVID vaccine makers dropped after the Washington Post reported that Trump administration health officials plan to publicly link the vaccines and child deaths.Shares of companies that make...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna, Pfizer Stocks Fall as Trump Officials Reportedly Link COVID Shots to Child Deaths","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","SG9999002232.USD","BK4585","IE00B3T34201.USD","BK4548","BK4592","LU0225771236.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU1267930573.SGD","LU0128525929.USD","LINK.USD.HKCC","LU1267930813.SGD","LU0456855351.SGD","BK4139","LU0058720904.USD","IE0002270589.USD","BK4534","BK4532","LU0321505439.SGD","BK4535","NVAX","SGXZ57979304.SGD","SG9999011175.SGD","LU0321505868.SGD","LU1066053197.SGD","PFE","BK4550","BK4581","LU1057294990.SGD","LU1883839398.USD","BNTX","LU0306806265.USD","LU1066051498.USD","IE00BLSP4239.USD","BK4568","LU0708994859.HKD","SG9999002224.SGD","BK4007","LU0985481810.HKD","IE00BLSP4452.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1894683348.USD","SG9999013999.USD","IE00B19Z3581.USD","LU0792757196.USD","SG9999001176.SGD","MRNA","LU0029864427.USD"],"gpt_icon":0},{"id":"2567907151","title":"Why BioNTech Stock Sank by More Than 7% Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2567907151","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567907151?lang=en_us&edition=fundamental","pubTime":"2025-09-13 06:19","pubTimestamp":1757715540,"startTime":"0","endTime":"0","summary":"The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future..","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833490%2Fperson-about-to-receive-a-vaccine-shot.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833490%2Fperson-about-to-receive-a-vaccine-shot.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/09/12/why-biontech-stock-sank-by-more-than-7-today/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/09/12/why-biontech-stock-sank-by-more-than-7-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0306806265.USD","LU0868494617.USD","SG9999013999.USD","LU0225284248.USD","CDC","LU1023059063.AUD","BK4592","LU0321505439.SGD","SG9999001176.SGD","BK4533","BK4588","LU1883839398.USD","BK4599","BK4585","IE000M9KFDE8.USD","LU0321505868.SGD","LU0306807586.USD","SG9999001176.USD","LU0058720904.USD","IE00BLSP4452.SGD","LU0170899867.USD","PFE","LU0122379950.USD","IE0002270589.USD","LU1894683348.USD","SG9999003800.SGD","IE00BBT3K403.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4534","LU1894683264.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU1057294990.SGD","LU0234572021.USD","IE00B19Z3581.USD","SG9999011175.SGD","IE00BLSP4239.USD","BK4581","BK4007","LU0289739699.SGD","BK4550","LU0985481810.HKD","SG9999002224.SGD","BK4568","SG9999002232.USD","LU0225771236.USD"],"gpt_icon":0},{"id":"2567904951","title":"Gilead beats whistleblower lawsuit over hepatitis C drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2567904951","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567904951?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:41","pubTimestamp":1757709712,"startTime":"0","endTime":"0","summary":"Gilead beats whistleblower lawsuit over hepatitis C drugsJudge said no evidence to support claims of kickbacks on Harvoni, SovaldiWhistleblower will appeal, his lawyers sayGilead settled claims of kic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL6N3UZ0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU2087621335.USD","BK4139","LU0289739699.SGD","LU0234570918.USD","IE00B19Z3581.USD","SG9999015952.SGD","BK4566","IE0002270589.USD","BK4583","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0889565916.HKD","LU1066053197.SGD","BK4585","LU1674673691.USD","LU1674673428.USD","LU0882574055.USD","LU2324357040.USD","LU1839511570.USD","BK4550","IE00B7SZLL34.SGD","SG9999015986.USD","GILD","IE00B19Z3B42.SGD","LU1571399168.USD","LU2468319806.SGD","BK4568","BK4588","LU1066051498.USD","SG9999015978.USD","LU1778281490.HKD","LU2089984988.USD","LU0823416689.USD","LU0320765992.SGD","LU1430594728.SGD","SG9999015945.SGD","LU1585245621.USD","BK4578","IE00BZ1G4Q59.USD","BK4532","IE00BSNM7G36.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2567190461","title":"Aethlon Medical Announces New Share Structure Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567190461?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:31","pubTimestamp":1757709085,"startTime":"0","endTime":"0","summary":"Aethlon Medical ( ($AEMD) ) has provided an update. On September 12, 2025, Aethlon Medical, Inc. announced that following a recent financing throug...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-announces-new-share-structure-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-announces-new-share-structure-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4583","BK4082","AEMD"],"gpt_icon":0},{"id":"2567905987","title":"AstraZeneca pauses planned $270M investment in Britain, Reuters reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2567905987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567905987?lang=en_us&edition=fundamental","pubTime":"2025-09-13 01:00","pubTimestamp":1757696428,"startTime":"0","endTime":"0","summary":"Britain’s biggest company AstraZeneca (AZN) has paused a planned $271.26M investment in its Cambridge research site, a spokesperson said, the lates...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-pauses-planned-270m-investment-in-britain-reuters-reports-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-pauses-planned-270m-investment-in-britain-reuters-reports-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","LU2236285917.USD","AZN","LU1829250122.USD","BK4568","LU0889565916.HKD","LU2462157665.USD","LU0320765992.SGD","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2567903765","title":"US Hhs Says Until Vaccine Safety Data Is Publicly Shared, All Reports on It Should Be Considered Pure Speculation","url":"https://stock-news.laohu8.com/highlight/detail?id=2567903765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567903765?lang=en_us&edition=fundamental","pubTime":"2025-09-13 00:44","pubTimestamp":1757695479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3N3UZ13K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","LU1066053197.SGD","IE00B19Z3581.USD","MRNA","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","BK4581","BK4007","LU0058720904.USD","LU0456855351.SGD","SG9999011175.SGD","LU1066051498.USD","LU1894683264.USD","IE00BLSP4239.USD","BK4585","PFE","IE00B19Z3B42.SGD","LU1883839398.USD","LU1057294990.SGD","LU0306806265.USD","IE000M9KFDE8.USD","LU1894683348.USD","SG9999002224.SGD","SG9999003800.SGD","LU0306807586.USD","LU0985481810.HKD","BK4532","BK4501","BK4139","SG9999002232.USD","LU0225771236.USD","BK4548","BK4550","IE00BBT3K403.USD","LU0868494617.USD","SG9999013999.USD","LU0170899867.USD","LU0289739699.SGD","LU0122379950.USD","BK4599","IE0002270589.USD","SG9999001176.USD","BK4592","BK4588","BK4568","LU0225284248.USD","LU0234572021.USD","LU0321505439.SGD","LU0321505868.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":197,"code":"91000000","status":"200"}]}}